DataMeds AI, Inc. Basic Shares Outstanding (Weighted Average)
DataMeds AI, Inc. (MEDS) reported Basic Shares Outstanding (Weighted Average) of 2.57 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-17
- DataMeds AI, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 2.57M shares, a 108.40% increase year-over-year.
- DataMeds AI, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 104.62M shares, a 101.52% increase year-over-year.
- DataMeds AI, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 96.57M shares, a 97.96% increase year-over-year.
- DataMeds AI, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 74.38M shares, a 53.66% increase year-over-year.
- DataMeds AI, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 70.99M shares, a 50.23% increase from fiscal 2024.
- DataMeds AI, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 47.25M shares, a 5.66% increase from fiscal 2023.
- DataMeds AI, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 44.72M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 2.57M shares 10-Q · filed 2026-08-17 | 2.34M shares 10-Q · filed 2026-08-17 | 67.92M shares derived: average of 3 quarters · filed 2026-08-17 | 69.54M shares derived: average of 4 quarters · filed 2026-08-17 | ||
| 2026-03-31 | 104.62M shares 10-Q · filed 2026-05-19 | 100.60M shares derived: average of 2 quarters · filed 2026-05-19 | 91.86M shares derived: average of 3 quarters · filed 2026-05-19 | 69.20M shares derived: average of 4 quarters · filed 2026-08-17 | ||
| 2025-12-31 | 96.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | 85.47M shares derived: average of 2 quarters · filed 2026-03-20 | 57.40M shares derived: average of 3 quarters · filed 2026-08-17 | 70.99M shares 10-K · filed 2026-03-20 | ||
| 2025-09-30 | 74.38M shares 10-Q · filed 2025-11-19 | 37.81M shares derived: average of 2 quarters · filed 2026-08-17 | 62.46M shares 10-Q · filed 2025-11-19 | 44.08M shares derived: average of 4 quarters · filed 2026-08-17 | ||
| 2025-06-30 | 1.24M shares 10-Q · filed 2026-08-17 | 61.77M shares 10-Q · filed 2025-08-19 | 1.14M shares 10-Q · filed 2026-08-17 | 56.86M shares 10-Q · filed 2025-08-19 | 33.98M shares derived: average of 3 quarters · filed 2026-08-17 | 37.58M shares derived: average of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | 51.92M shares 10-Q · filed 2026-05-19 | 50.35M shares derived: average of 2 quarters · filed 2026-05-19 | 49.70M shares derived: average of 3 quarters · filed 2026-05-19 | 48.75M shares derived: average of 4 quarters · filed 2026-05-19 | ||
| 2024-12-31 | 48.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | 48.59M shares derived: average of 2 quarters · filed 2026-03-20 | 47.70M shares derived: average of 3 quarters · filed 2026-03-20 | 47.25M shares 10-K · filed 2026-03-20 | ||
| 2024-09-30 | 48.40M shares 10-Q · filed 2025-11-19 | 47.15M shares derived: average of 2 quarters · filed 2025-11-19 | 46.74M shares 10-Q · filed 2025-11-19 | |||
| 2024-06-30 | 45.90M shares 10-Q · filed 2025-08-19 | 46.84M shares 10-Q · filed 2025-08-19 | ||||
| 2024-03-31 | 44.72M shares 10-Q · filed 2025-05-12 | |||||
| 2023-12-31 | 44.72M shares 10-K · filed 2025-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |